Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clozapine in young people with treatment-resistant psychosis
ISRCTN37176025Phase 4Active, not recruiting
- Sponsor
- King's College London
- Start
- Nov 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 4, single-blind trial of clozapine in schizophrenia and Schizophrenia Spectrum Disorders (SSD) (2 arms), sponsored by King's College London. Started Nov 2023; status: active, not recruiting.
02
Drugs
clozapine
03
Conditions
schizophreniaSchizophrenia Spectrum Disorders (SSD)
Beyond the preview
Go deeper on ISRCTN37176025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN37176025.